Quipt Home Medical Corp.

NasdaqCM:QIPT Stock Report

Market Cap: US$140.8m

Quipt Home Medical Management

Management criteria checks 4/4

Quipt Home Medical's CEO is Greg Crawford, appointed in Dec 2017, has a tenure of 7.17 years. total yearly compensation is $712.11K, comprised of 95.6% salary and 4.4% bonuses, including company stock and options. directly owns 6.85% of the company’s shares, worth $9.65M. The average tenure of the management team and the board of directors is 7 years and 7.2 years respectively.

Key information

Greg Crawford

Chief executive officer

US$712.1k

Total compensation

CEO salary percentage95.6%
CEO tenure7.2yrs
CEO ownership6.9%
Management average tenure7yrs
Board average tenure7.2yrs

Recent management updates

Recent updates

Quipt Home Medical receives commitment letter for $80M of credit facilities

Aug 15

Quipt Business Progresses, Stock Price Should Soon Follow

Jul 26

Quipt acquires Hometown Medical, scoops fourth firm in four months

Jul 11

Quipt: At A Turning Point, Seeking 40% Return Objective

Jun 29

Quipt Convertible Debenture Hedging Provides An Incredible Opportunity

Apr 04

Quipt's Recent Announcements Signal Good Times Ahead

Nov 30

Quipt Home Medical: Acquisitions And Earnings Breathe Life Back Into Shares

Aug 31

Quipt: Warrant Overhang Creates Attractive Prices

Jun 18

CEO Compensation Analysis

How has Greg Crawford's remuneration changed compared to Quipt Home Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024US$712kUS$681k

-US$7m

Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023n/an/a

-US$4m

Sep 30 2023US$2mUS$597k

-US$3m

Jun 30 2023n/an/a

US$310k

Mar 31 2023n/an/a

US$2m

Dec 31 2022n/an/a

US$7m

Sep 30 2022US$843kUS$558k

US$5m

Jun 30 2022n/an/a

US$2m

Mar 31 2022n/an/a

US$8m

Dec 31 2021n/an/a

-US$10m

Sep 30 2021US$4mUS$513k

-US$6m

Jun 30 2021n/an/a

-US$5m

Mar 31 2021n/an/a

-US$14m

Dec 31 2020n/an/a

US$1m

Sep 30 2020US$440kUS$425k

-US$4m

Jun 30 2020n/an/a

US$428k

Mar 31 2020n/an/a

-US$6m

Dec 31 2019n/an/a

-US$11m

Sep 30 2019US$652kUS$425k

-US$7m

Jun 30 2019n/an/a

-US$27m

Mar 31 2019n/an/a

-US$18m

Dec 31 2018n/an/a

-US$20m

Sep 30 2018US$1mUS$418k

-US$7m

Compensation vs Market: Greg's total compensation ($USD712.11K) is about average for companies of similar size in the US market ($USD640.92K).

Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.

CEO

Greg Crawford (50 yo)

7.2yrs

Tenure

US$712,106

Compensation

Mr. Gregory J. Crawford also known as Greg, serves as Director at DMEscripts LLC. He has been President, Chief Executive Officer and Chairman of Quipt Home Medical Corp. (formerly known as Protech Home Med...

Leadership Team

NamePositionTenureCompensationOwnership
Gregory Crawford
Chairman7.2yrsUS$712.11k6.85%
$ 9.6m
Hardik Mehta
Chief Financial Officer7yrsUS$597.18k1.84%
$ 2.6m
Thomas Roehrig
Chief Accounting Officerno dataUS$249.14k0.055%
$ 77.2k
William Zehnder
Chief Strategy Officer & Investor Relationsno dataUS$308.24kno data
Mark Miles
Chief Compliance Officerless than a yearno datano data
Cole Stevens
VP of Corporate Development & VP of Investor Relationsno datano datano data
David Bachelder
Executive Vice President of Operationsno datano data0.0050%
$ 7.0k
Patrick Gamble
Executive Vice President of Operationsless than a yearno data0.093%
$ 130.9k
Robert Grossman
Corporate Secretary13.1yrsno datano data

7.0yrs

Average Tenure

50yo

Average Age

Experienced Management: QIPT's management team is seasoned and experienced (7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Gregory Crawford
Chairman7.2yrsUS$712.11k6.85%
$ 9.6m
Mark Greenberg
Independent Non Executive Director7.2yrsUS$150.00k0.47%
$ 657.4k
Steven Axelrod
Member of the Board of Advisors11.3yrsno datano data
Jim Booth
Member of the Board of Advisors11.3yrsno datano data
Kevin Carter
Independent Non-Executive Director4.2yrsUS$476.95k0.12%
$ 163.4k
Brian Wessel
Independent Director3yrsUS$80.00k0.098%
$ 138.5k

7.2yrs

Average Tenure

53.5yo

Average Age

Experienced Board: QIPT's board of directors are considered experienced (7.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/02 04:32
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Quipt Home Medical Corp. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
William SutherlandBenchmark Company
Richard CloseCanaccord Genuity